NEW YORK (360Dx) – A point-of-care test that monitors the immune system's response without requiring manual processing could help clinicians treating sepsis, a condition that should be quickly detected to provide an optimal clinical effect, according to the test's developers at the University of Illinois and the Carle Foundation Hospital in Urbana, Illinois.

To monitor the immune system's response during infection or inflammation, the test looks for an increase in the expression of the CD64 protein marker on specific types of white blood cells called neutrophils.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.